Table 1.
Patient characteristics
| Total (n = 166) | |
|---|---|
| Gender | |
| Male | n = 123 (74 %) |
| Female | n = 43 (26 %) |
| Age (years) | 50 [31–67] |
| Injury severity score | 26 [17–37] |
| Head/neck injury (ISS region 1) | n = 129, 78 % |
| Face injury (ISS region 2) | n = 47, 28 % |
| Chest injury (ISS region 3) | n = 96, 58 % |
| Abdomen or pelvic contents injury (ISS region 4) | n = 44, 27 % |
| Extremities or pelvic girdle injury (ISS region 5) | n = 78, 47 % |
| External injury (ISS region 6) | n = 77, 46 % |
| ICU admissiona | n = 101 (61 %) |
| Mechanical ventilationa | n = 96 (95 %) |
| Vasopressor therapya | n = 35 (35 %) |
| ICU length of stay (days) | 3 [1–7] |
| Corticosteroids administereda | n = 8 (5 %) |
| Transfusion of blood productsa | n = 24 (14 %) |
| Hospital length of stay (days) | 8 [1–17] |
| 28-day survival | n = 127 (77 %) |
| 28-day survival (among initial trauma survivors) | n = 127/147 (86 %) |
Initial trauma survivors were defined as patients who survived the initial 7 days following trauma. Vasopressor therapy always consisted of noradrenaline. Corticosteroids included all types of administration. Blood products included erythrocytes, thrombocytes, and fresh frozen plasma
aAdmitted to or used within 28 days after hospital admission